《Seminars In Hematology》雜志的最新年發文量為36篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在血液學領域的學術影響力。
該刊聚焦于醫學-血液學領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 12周，或約稿 。
Seminars In Hematology 雜志發文統計
文章名稱引用次數
- MRD Testing in Multiple Myeloma: The Main Future Driver for Modern Tailored Treatment13
- The 2016 WHO classification of acute myeloid leukemia: What the practicing clinician needs to know11
- Mass spectrometry methods for detecting monoclonal immunoglobulins in multiple myeloma minimal residual disease10
- Will CAR T cell therapy have a role in AML? Promises and pitfalls10
- Immune reconstitution after T-cell replete HLA-haploidentical transplantation9
- Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease9
- Complement in Pathophysiology and Treatment of Transplant -Associated Thrombotic Microangiopathies9
- Functional Imaging Methods for Assessment of Minimal Residual Disease in Multiple Myeloma: Current Status and Novel ImmunoPET Based Methods8
- Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a large multicenter study7
- Fetal Hemoglobin Induction by Epigenetic Drugs7
國家/地區發文量
- USA68
- Italy10
- CHINA MAINLAND6
- France5
- Canada4
- England4
- GERMANY (FED REP GER)4
- Australia3
- Israel2
- Netherlands2
